aluminum chloride-hydroxide Cutaneous solution 20% w/v

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #17479
The firm has spent the last 55 years studying and developing new dermatological therapies. In the 1960s, a doctor founded the organization. It's one of the few completely autonomous pharmaceutical enterprises in Europe. The company's specialty is in the development of extremely effective yet aesthetically pleasing skin treatments. They're commonly given for several skin ailments including eczema (dermatitis), psoriasis, and ichthyosis, as well as other conditions that can be treated with medication.

Manufacturer usually replies in 64 days